Anyone heard about new trial for erythromelalgia? Read this about a potential new treatment from swedish Pila pharma

https://pilapharma.com/press-release/Pila

Pharma is developing XEN-D0501, an oral TRPV1 antagonist, as a potential treatment for the rare, painful, and often debilitating disease erythromelalgia. The company received orphan drug designation for this indication in 2022 and is preparing to submit a clinical trial application in the first half of 2026 for a proof-of-concept